Statement | 30 April 2014 Intellectual property and trade India MSF responds to US Trade 301 Watch List 2 min
Statement | 30 April 2014 Antimicrobial resistance MSF reponse to WHO report on antimicrobial resistance 1 min
Statement | 08 March 2014 Intellectual property and trade United States of America USTR’s proposal for the Intellectual Property Chapter of the TPP will endanger access to medicines for all
Statement | 04 March 2014 Vaccines MSF responds to inactivated polio vaccine price announcement 3 min
Statement | 24 February 2014 Intellectual property and trade European Union MSF response to European Parliament proposals of EU enforcement of European trademarks on goods in transit 3 min
Statement | 21 February 2014 HIV/AIDS MSF response to the licensing deal announced between Merck Sharp & Dohme and Cipla for the HIV medicine raltegravir 3 min
Statement | 17 February 2014 Intellectual property and trade India MSF oral testimony to the United States International Trade Commission public hearing 12 min
Statement | 07 February 2014 Hepatitis C MSF responds to reports on Gilead pricing for hepatitis C drug sofosbuvir in developing countries 2 min
